
浏览全部资源
扫码关注微信
400042 重庆,陆军特色医学中心战伤休克与输血研究室,创伤、烧伤与复合伤国家重点实验室
[ 李涛,E-mail:lt200132@tmmu.edu.cn LI Tao, E-mail: lt200132@tmmu.edu.cn
收稿:2022-05-10,
修回:2022-07-15,
纸质出版:2022-10-30
移动端阅览
吴跃, 朱娱, 周远群, 等. 线粒体分裂抑制剂Mdivi-1对高原战创伤休克大鼠的保护作用[J]. 陆军军医大学学报, 2022,44(20):2030-2036.
Yue WU, Yu ZHU, Yuanqun ZHOU, et al. Protective effects of mitochondrial fission inhibitor, Mdivi-1, on traumatic shock rats at high altitude[J]. Journal of Army Medical University, 2022, 44(20): 2030-2036.
吴跃, 朱娱, 周远群, 等. 线粒体分裂抑制剂Mdivi-1对高原战创伤休克大鼠的保护作用[J]. 陆军军医大学学报, 2022,44(20):2030-2036. DOI: 10.16016/j.2097-0927.202205040.
Yue WU, Yu ZHU, Yuanqun ZHOU, et al. Protective effects of mitochondrial fission inhibitor, Mdivi-1, on traumatic shock rats at high altitude[J]. Journal of Army Medical University, 2022, 44(20): 2030-2036. DOI: 10.16016/j.2097-0927.202205040.
目的
2
观察线粒体分裂抑制剂(mitochondrial division inhibitor-1,Mdivi-1)对高原战创伤休克的早期救治作用。
方法
2
SD大鼠从平原(重庆)急进(空运)至高原(拉萨,海拔3 600 m)72 h后,通过脾动脉离断自由出血至平均动脉血压(mean arterial pressure,MAP)降至40 mmHg,建立高原战创伤休克模型。实验分为假手术组、休克组、乳酸林格氏液(Lactate Ringer’s,LR)对照组、0.1和0.5 mg/kg Mdivi-1组。实验分两部分,第一部分大鼠不接受止血处理,仅采用LR或联合0.1、0.5 mg/kg Mdivi-1进行复苏,将MAP维持在50~60 mmHg,观察大鼠血压、失血量、输液量以及存活的变化;第二部分低压复苏1 h后,经彻底止血后进行确定性复苏,观察大鼠失血量、输液量、器官功能、组织氧分压、肺脑含水量以及动物存活情况的变化。
结果
2
在不进行止血处理时,采用LR进行低压复苏,大鼠MAP可维持在50~60 mmHg约1 h。而后增加液体输入量,MAP不升高反而进行性降低,且失血量明显增加。Mdivi-1联合低压复苏能将MAP较好地维持在50~60 mmHg约3 h;与LR对照组相比,大鼠失血量、输液量显著减少。低压复苏1 h、行止血及确定性治疗后,单纯LR复苏大鼠的组织氧分压仍在较低水平,同时肺脑含水量增加,重要器官如心、肝和肾脏功能受损严重;而给予0.1或0.5 mg/kg Mdivi-1后大鼠的组织氧分压明显提高,肺脑含水量降低,心、肝和肾脏功能受损明显减轻,与LR对照组相比,大鼠存活明显延长。
结论
2
Mdivi-1适用于高原战创伤休克的早期救治,可改善器官功能,延长黄金救治时间窗。
Objective
2
To observe the early therapeutic effects of a mitochondrial fission inhibitor
mitochondrial division inhibitor 1 (Mdivi-1)
on the traumatic shock rats at high altitude.
Methods
2
SD rats were rapidly transported (airlift) from the plain (Chongqing) to the plateau (Lhasa
3 600 m altitude). After 72 h
the traumatic shock model of rats at high altitude was prepared by free bleeding from splenic artery disconnection until mean arterial pressure (MAP) fell to 40 mmHg. The animals were divided into 5 groups: sham-operation group
shock group
Lactate Ringer's (LR) solution control group
and LR combined with 0.1 and 0.5 mg/kg Mdivi-1 groups. Then the experiments were designed as 2 parts. The rats in the first part were resuscitated with mere LR solution or combined with 0.1 or 0.5 mg/kg Mdivi-1 without hemostatic treatment. With the MAP maintained at 50-60 mmHg
the changes of MAP
bleeding volume
fluid infusion volume and survival rate were observed in each group. In the second part
bleeding control was performed by ligation of the spleen artery after 1 h of low-pressure resuscitation
and definitive resuscitation was continuously given. The changes of blood loss
infusion volume
organ functions
tissue oxygen partial pressure
lung and brain water content and animal survival were subsequently investigated.
Results
2
When LR solution was used for low-pressure resuscitation without hemostatic treatment
the MAP of rats was maintained at 50-60 mmHg for about 1 h
and then began to drop gradually rather than rise after increasing the amount of fluid input
with the bleeding volume soared obviously. Whereas Mdivi-1 combination treatment maintained MAP at 50-60 mmHg for about 3 h
and significantly reduced the bleeding volume and fluid infusion. Further studies showed that in the hemostatic resuscitation treatment
the rats of the LR control group still had a rather low level of tissue oxygen partial pressure
with elevated water contents in the lung and brain
and seriously impaired functions of vital organs such as the heart
liver and kidney. However
Mdivi-1 (0.1 or 0.5 mg/kg) treatment remarkably improved the damage
increased the tissue oxygen partial pressure
reduced the water contents in the lung and brain
alleviated the impairment of the heart
liver and kidney
and greatly prolonged the survival time of shock animals.
Conclusion
2
Mdivi-1 is suitable for the early treatment of traumatic shock at high altitude
which can improve organ functions and extend the golden time of treatment.
LIU L M, TIAN K L, XUE M Y, et al . Small doses of arginine vasopressin in combination with norepinephrine "buy" time for definitive treatment for uncontrolled hemorrhagic shock in rats[J ] . Shock, 2013, 40(5): 398-406. DOI: 10.1097/SHK.0000000000000036.
CHERKAS D. Traumatichemorrhagic shock: advances in fluid management[J]. Emerg Med Pract, 2011, 13(11): 1-19;quiz19-20.
BOGERT J N, HARVIN J A, COTTON B A. Damage control resuscitation[J]. J Intensive Care Med, 2016, 31(3): 177-186. DOI: 10.1177/0885066614558018.
BOUGLÉ A, HARROIS A, DURANTEAU J. Resuscitative strategies in traumatic hemorrhagic shock[J]. Ann Intensive Care, 2013, 3(1): 1. DOI: 10.1186/2110-5820-3-1.
ZHANG J, WU Y, PENG X Y, et al . The protective effect of a novel cross-linked hemoglob in-based oxygen carrier on hypoxia injury of acute mountain sickness in rabbits and goats[J ] . Front Physiol, 2021, 12: 690190. DOI: 10.3389/fphys.2021.690190.
DUAN C Y, WANG L, ZHANG J, et al . Mdivi-1 attenuates oxidative stress and exerts vascular protection in ischemic/hypoxic injury by a mechanism independent of Drp1 GTPase activity[J ] . Redox Biol, 2020, 37: 101706. DOI: 10.1016/j.redox.2020.101706.
FORTE M, SCHIRONE L, AMERI P, et al . The role of mitochondrial dynamics in cardiovascular diseases[J ] . Br J Pharmacol, 2021, 178(10): 2060-2076. DOI: 10.1111/bph.15068.
KOCH B, TRAVEN A. Mdivi-1 and mitochondrial fission: recent insights from fungal pathogens[J]. Curr Genet, 2019, 65(4): 837-845. DOI: 10.1007/s00294-019-00942-6.
ZHANG Y G, RUI T Y, LUO C L, et al . Mdivi-1 alleviates brain damage and synaptic dysfunction after intracerebral hemorrhage in mice[J ] . Exp Brain Res, 2021, 239(5): 1581-1593. DOI: 10.1007/s00221-021-06089-6.
刘良明. 创伤失血性休克早期救治规范解读[J]. 创伤外科杂志, 2017, 19(12): 884-887. DOI: 10.3969/j.issn.1009-4237.2017.12.002.
LIU L M. Interpretation of the standard for early treatment of traumatic hemorrhagic shock[J]. J Trauma Surg, 2017, 19(12): 884-887. DOI: 10.3969/j.issn.1009-4237.2017.12.002.
李涛, 胡平, 胡弋, 等. 院前适度低压复苏对严重创伤出血患者器官功能保护作用观察[J]. 创伤外科杂志, 2018, 20(8): 595-599. DOI: 10.3969/j.issn.1009-4237.2018.08.009.
LI T, HU P, HU Y, et al . Effects of permissive hypotensive resuscitation during pre-hospital for severe traumatic patients[J ] . J Trauma Surg, 2018, 20(8): 595-599. DOI: 10.3969/j.issn.1009-4237.2018.08.009.
徐崇. 高海拔地区高压氧联合药物治疗急性高原肺水肿的临床效果分析[J]. 中外医学研究, 2018, 16(32): 17-18. DOI: 10.14033/j.cnki.cfmr.2018.32.008.
XU C. Analysis of clinical efficacy of high altitude hyperbaric oxygen combined with drug therapy for acute high altitude pulmonary edema at high altitude[J]. Chin Foreign Med Res, 2018, 16(32): 17-18. DOI: 10.14033/j.cnki.cfmr.2018.32.008.
ZHAO H L, ZHU Y, ZHANG J, et al . The beneficial effect of HES on vascular permeability and its relationship with endothelial glycocalyx and intercellular junction after hemorrhagic shock[J ] . Front Pharmacol, 2020, 11: 597. DOI: 10.3389/fphar.2020.00597.
PROTASONI M, ZEVIANI M. Mitochondrial structure and bioenergetics in normal and disease conditions[J]. Int J Mol Sci, 2021, 22(2): 586. DOI: 10.3390/ijms22020586.
黄艳平, 杨天华, 金植炎, 等. 线粒体通透性转换孔在内吗啡肽-1后处理减轻大鼠心肌缺血再灌注损伤中的作用[J]. 南方医科大学学报, 2018, 38(5): 547-553. DOI: 10.3969/j.issn.1673-4254.2018.05.07.
HUANG Y P, YANG T H, JIN Z Y, et al . Role of mitochondrial permeability transition pore in mediating the effect of endomorphin-1 postconditioning against myocardial ischemia-reperfusion injury in rats[J ] . J Southern Med Univ, 2018, 38(5): 547-553. DOI: 10.3969/j.issn.1673-4254.2018.05.07.
SABOUNY R, SHUTT T E. Reciprocal regulation of mitochondrial fission and fusion[J]. Trends Biochem Sci, 2020, 45(7): 564-577. DOI: 10.1016/j.tibs.2020.03.009.
CHIU Y H, LIN S C A, KUO C H, et al . Molecular machinery and pathophysiology of mitochondrial dynamics[J ] . Front Cell Dev Biol, 2021, 9: 743892. DOI: 10.3389/fcell.2021.743892.
WU W X, LI W, CHEN H, et al . FUNDC1 is a novel mitochondrial-associated-membrane (MAM) protein required for hypoxia-induced mitochondrial fission and mitophagy[J ] . Autophagy, 2016, 12(9): 1675-1676. DOI: 10.1080/15548627.2016.1193656.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621